Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Skywest
SKYW
$4.42B
| $7.35M | ﹤0.01% |
73,014
-156,727
| -68% | -$17.5M |
|
|
CPRX
1902
DELISTED
Catalyst Pharmaceutical
CPRX
| $7.35M | ﹤0.01% |
372,892
+4,056
| +1% | +$83.4K |
|
1903
Qorvo
QRVO
$7.89B
| $7.33M | ﹤0.01% |
80,510
-1,215,691
| -94% | -$108M |
|
1904
ANI Pharmaceuticals
ANIP
$1.82B
| $7.33M | ﹤0.01% |
80,031
-104,608
| -57% | -$8.53M |
|
1905
PUT
Sharplink Inc
SBET
$1.33B
| $7.32M | ﹤0.01% |
+430,400
| New | +$8.45M |
|
1906
Ardagh Metal Packaging
AMBP
$2.87B
| $7.32M | ﹤0.01% |
1,834,361
+1,299,132
| +243% | +$5.17M |
|
|
CRWV
1907
CALL
CoreWeave
CRWV
$50.1B
| $7.31M | ﹤0.01% |
53,400
+24,900
| +87% | +$2.95M |
|
1908
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $7.3M | ﹤0.01% |
111,932
-427,845
| -79% | -$27.5M |
|
1909
CALL
Cytokinetics
CYTK
$10.7B
| $7.29M | ﹤0.01% |
132,600
+132,400
| +66,200% | +$5.45M |
|
1910
Ubiquiti
UI
$33.2B
| $7.29M | ﹤0.01% |
11,030
-10,485
| -49% | -$5.23M |
|
|
PCH
1911
DELISTED
PotlatchDeltic
PCH
| $7.27M | ﹤0.01% |
178,346
+5,844
| +3% | +$242K |
|
1912
PUT
Pfizer
PFE
$145B
| $7.26M | ﹤0.01% |
285,100
-2,949,800
| -91% | -$72.8M |
|
1913
CALL
Citizens Financial Group
CFG
$30.7B
| $7.25M | ﹤0.01% |
+136,400
| New | +$6.79M |
|
|
1914
PUT
Citizens Financial Group
CFG
$30.7B
| $7.25M | ﹤0.01% |
+136,400
| New | +$6.79M |
|
1915
StepStone Group
STEP
$3.83B
| $7.25M | ﹤0.01% |
111,012
-84,843
| -43% | -$5.18M |
|
1916
NewMarket
NEU
$7.86B
| $7.25M | ﹤0.01% |
8,753
-11,816
| -57% | -$9.1M |
|
1917
Avient
AVNT
$3.43B
| $7.22M | ﹤0.01% |
219,237
+8,773
| +4% | +$305K |
|
1918
Valaris
VAL
$5.32B
| $7.2M | ﹤0.01% |
147,664
-41,623
| -22% | -$2.03M |
|
1919
CALL
Mobileye
MBLY
$2.18B
| $7.2M | ﹤0.01% |
510,000
-343,500
| -40% | -$5.11M |
|
1920
PUT
Amgen
AMGN
$210B
| $7.2M | ﹤0.01% |
25,500
-404,800
| -94% | -$117M |
|
1921
CALL
RTX Corp
RTX
$292B
| $7.18M | ﹤0.01% |
42,900
-989,200
| -96% | -$154M |
|
1922
ESAB
ESAB
$5.66B
| $7.17M | ﹤0.01% |
64,199
+37,427
| +140% | +$4.45M |
|
|
LNW
1923
DELISTED
Light & Wonder
LNW
| $7.16M | ﹤0.01% |
85,252
-20,602
| -19% | -$1.89M |
|
1924
Gulfport Energy Corp
GPOR
$2.94B
| $7.15M | ﹤0.01% |
39,503
-24,753
| -39% | -$4.31M |
|
|
1925
PUT
Walmart Inc
WMT
$888B
| $7.14M | ﹤0.01% |
69,300
-1,439,700
| -95% | -$143M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.